Literature DB >> 3800656

Homotypic and heterotypic immunity of influenza A viruses induced by recombinants of the cold-adapted master strain A/Ann Arbor/6/60-ca.

G A Tannock, J A Paul.   

Abstract

The cold-adapted (ca) influenza A virus A/Ann Arbor/6/60-ca when administered intranasally to mice in two doses 3 weeks apart induces solid immunity to challenge 3 weeks later with heterotypic influenza A wild-type viruses (17). In the present study heterotypic immunity against viruses from different sub-types was shown to be relatively short-lived, having declined significantly 9 weeks after vaccination and being completely absent by 21 weeks. On the other hand, immunity against challenge viruses with surface antigens similar to the ca vaccinating virus or to other H 3 N 2 viruses remained high, even in the absence of detectable serum haemagglutination-inhibiting antibody. Both short- and long-term immunity induced by ca viruses was unaffected by earlier priming experiences with other wild-type or ca viruses. These results suggest that at least two mechanisms are involved in respiratory immunity to influenza viruses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3800656     DOI: 10.1007/bf01310067

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  14 in total

1.  Heterogeneity of the cytotoxic response of thymus-derived lymphocytes after immunization with influenza viruses.

Authors:  P C Doherty; R B Effros; J Bennink
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

2.  Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine.

Authors:  M L Clements; R F Betts; E L Tierney; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

3.  Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens.

Authors:  G A Tannock; J A Paul; R D Barry
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

4.  Characteristics of secondary cytotoxic T-cell responses in mice infected with influenza A viruses.

Authors:  R B Effros; J Bennink; P C Doherty
Journal:  Cell Immunol       Date:  1978-03-15       Impact factor: 4.868

5.  Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic strains and cold-adapted A/An Arbor/6/60.

Authors:  N J Cox; H F Maassab; A P Kendal
Journal:  Virology       Date:  1979-08       Impact factor: 3.616

6.  A murine model for assessment of living attenuated influenza A vaccines.

Authors:  M C Wark; G A Tannock; M M Sutherland; L E Smith
Journal:  Aust J Exp Biol Med Sci       Date:  1980-12

7.  Morphological characterization of a cell population responsible for natural killer activity.

Authors:  W Luini; D Boraschi; S Alberti; A Aleotti; A Tagliabue
Journal:  Immunology       Date:  1981-08       Impact factor: 7.397

8.  Diminished T-cell response to influenza virus in aged mice.

Authors:  R B Effros; R L Walford
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

9.  The generation of 'cytotoxic' macrophages in mice during infection with influenza A or Sendai virus.

Authors:  N K Mak; K N Leung; G L Ada
Journal:  Scand J Immunol       Date:  1982-06       Impact factor: 3.487

10.  Antibody to influenza virus matrix protein detects a common antigen on the surface of cells infected with type A influenza viruses.

Authors:  W E Biddison; P C Doherty; R G Webster
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

View more
  10 in total

1.  Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses.

Authors:  Paula A Lanthier; Gail E Huston; Amy Moquin; Sheri M Eaton; Frank M Szaba; Lawrence W Kummer; Micheal P Tighe; Jacob E Kohlmeier; Patrick J Blair; Michael Broderick; Stephen T Smiley; Laura Haynes
Journal:  Vaccine       Date:  2011-08-02       Impact factor: 3.641

2.  The immunogenicity of reassortants of the cold-adapted influenza A master strain A/Ann Arbor/6/60 is determined by both the genes for cold-adaptation and the haemagglutinin gene.

Authors:  G A Tannock; J R Romanova; J A Paul
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

3.  A model for determining immunogenic relationships between avian infectious bronchitis viruses.

Authors:  Y Arvidson; G A Tannock; A Senthilselvan; M Zerbes
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  Immunity to the conserved influenza nucleoprotein reduces susceptibility to secondary bacterial infections.

Authors:  Laura Haynes; Frank M Szaba; Sheri M Eaton; Lawrence W Kummer; Paula A Lanthier; Ashlee H Petell; Debra K Duso; Deyan Luo; Jr-Shiuan Lin; Julie S Lefebvre; Troy D Randall; Lawrence L Johnson; Jacob E Kohlmeier; David L Woodland; Stephen T Smiley
Journal:  J Immunol       Date:  2012-10-01       Impact factor: 5.422

5.  Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunity.

Authors:  Timothy J Powell; Jonathan D Silk; Jane Sharps; Ervin Fodor; Alain R M Townsend
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

Review 6.  Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo.

Authors:  Suzanne L Epstein
Journal:  Am J Epidemiol       Date:  2018-12-01       Impact factor: 4.897

7.  Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice.

Authors:  Mark R Soboleski; Jon D Gabbard; Graeme E Price; Julia A Misplon; Chia-Yun Lo; Daniel R Perez; Jianqiang Ye; S Mark Tompkins; Suzanne L Epstein
Journal:  PLoS One       Date:  2011-07-15       Impact factor: 3.240

8.  Computational Characterization of Transient Strain-Transcending Immunity against Influenza A.

Authors:  David C Farrow; Donald S Burke; Roni Rosenfeld
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

9.  Age Dependence of Immunity Induced by a Candidate Universal Influenza Vaccine in Mice.

Authors:  Mayra García; Julia A Misplon; Graeme E Price; Chia-Yun Lo; Suzanne L Epstein
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

10.  Homotypic protection against influenza in a pediatric cohort in Managua, Nicaragua.

Authors:  Steph Wraith; Angel Balmaseda; Fausto Andres Bustos Carrillo; Guillermina Kuan; John Huddleston; John Kubale; Roger Lopez; Sergio Ojeda; Amy Schiller; Brenda Lopez; Nery Sanchez; Richard Webby; Martha I Nelson; Eva Harris; Aubree Gordon
Journal:  Nat Commun       Date:  2022-03-04       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.